The goals of comprehensive and integrated disease state management for diabetic kidney-disease patients

Advances in Chronic Kidney Disease

Volumn 12, Issue 2, 2005, Pages 236-242

  Goeddeke Merickel, Catherine M ^a  

^a NONE   (United States)

Author keywords

Cardiovascular disease; Diabetes; Hypertension; Kidney disease; Nutrition therapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CLINICAL PRACTICE; COUGHING; DIABETES CONTROL; DIABETIC DIET; DIABETIC HYPERTENSION; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG CONTRAINDICATION; HEALTH CARE QUALITY; HEALTH PROGRAM; HEART INFARCTION; HEMODIALYSIS; HIGH POTASSIUM INTAKE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; LIFESTYLE; MEDICAL CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT COMPLIANCE; PATIENT EDUCATION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN ALLERGY; SODIUM RESTRICTION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 16844366555     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2005.01.006     Document Type: Article

References (36)

1. Addressing the new diabetes epidemic. uncontrolled diabetes Proceedings of the New York Academy of Sciences 2003 June
2. M.E. Molitch, R.A. DeFronzo, M.J. Franz Nephropathy in diabetes Diabetes Care 27 suppl 2004 S79 S83
3. US Renal Data System USRDS 2004 Annual Report 2004 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
4. M.J. Franz Medical Nutrition Therapy for Diabetes Mellitus and Hypoglycemia of Nondiabetic Origin in Krause's Food, Nutrition, and Diet Therapy (ed 11) 2004 Saunders Philadelphia, PA
5. Centers for Disease Control and Prevention National Diabetes Fact Sheet General Information and National Estimates on Diabetes in the United States, 2002 2003 U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Atlanta, GA
6. World Health Organization Diabetes Mellitus Report of a WHO Study Group 1985 World Health Organization Geneva Tech Report #727.
7. A. Rosenbloom, S. Arslanian, S. Brink Type 2 diabetes in children and adolescents Diabetes Care 23 2000 381 389
8. S. Genuth, K.G.M.M. Alberti, P. Bennett The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 26 2003 3160 3167
9. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease Am J Kidney Dis 43 suppl 1 2004 S1 S268
10. G.L. Bakris, M. Williams, L. Dworkin National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group Preserving renal function in adults with hypertension and diabetes A consensus approach Am J Kidney Dis 36 2000 646 661
11. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease Am J Kidney Dis 43 suppl 1 2004 S142 S158
12. Department of Health and Human Services National Diabetes Fact Sheet 2003 November
13. Standards of medical care in diabetes Diabetes Care 27 suppl 2004 S15 S35
14. Summary of Revisions for the 2004 Clinical Practice Recommendations Diabetes Care 27 suppl 2004 S3
15. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
16. The UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
17. The UK Prospective Diabetes Study Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
18. The DCCT/EDIC Research Group Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy N Engl J Med 342 2000 381 389
19. M.L. Lawson, H.C. Gerstein, E. Tsui Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes Diabetes Care 22 suppl 1 1999 B35 B39
20. I.M. Stratton, A.I. Adler, H.A. Neil Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35) Prospective observational study BMJ 321 2000 405 412
21. C.D. Furberg, J.T. Wright, B.R. Davis Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
22. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus Results of the HOPE study and MICRO-HOPE study Lancet 355 2000 253 259
23. The Progress Collaborative Group Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack Lancet 358 2001 1033 1041
24. L.H. Lindholm, H. Ibsen, B. Dahlof Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint Reduction in Hypertension study (LIFE) A randomized trial against atenolol Lancet 359 2002 1004 1010
25. A.C. Schoolwerth, D.A. Sica, B.J. Ballermann Renal considerations in angiotensin converting enzyme inhibitor therapy A statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association Circulation 104 2001 1985 1991
26. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease Am J Kidney Dis 43 suppl 1 2004 S183 S205
27. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease Am J Kidney Dis 43 suppl 1 2004 S65 S73
28. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease Am J Kidney Dis 43 suppl 1 2004 S120 S141
29. A.V. Chobanian, G.L. Bakris, H.R. Black The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure The JNC 7 report JAMA 289 2003 2560 2572
30. L.J. Appel, T.J. Moore, E. Obarzanek A clinical trial of the effects of dietary patterns on blood pressure N Engl J Med 336 1997 1117 1124
31. Facts About the DASH Diet 1999 1 15 NHLBI
32. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Adult treatment panel III JAMA 285 2001 2486 2497
33. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatinin 5963 people with diabetes A randomized placebo-controlled trial Lancet 361 2003 2005 2016
34. Feet Can Last a Lifetime A Healthcare Provider's Guide to Preventing Diabetes Foot Problems 1998 National Diabetes Education Program (NDEP) Publication 1 50
35. Diabetes Clinical Care Guidelines. OMPRO Publication. Available at www.ompro.org. Updated July 2004
36. Guiding Principles for Diabetes Care For Healthcare Providers 2004 NDEP Publication 1 8